Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cord Blood (CB) Stability and Potency Evaluation: Consistent, Predictable Recovery of Hematopoietic Progenitor Cells (HPC) and High CD34+ Cell Viability.

Published byPatrick Jefferson Modified over 5 years ago

Similar presentations

Presentation on theme: "Cord Blood (CB) Stability and Potency Evaluation: Consistent, Predictable Recovery of Hematopoietic Progenitor Cells (HPC) and High CD34+ Cell Viability."— Presentation transcript:

1 Cord Blood (CB) Stability and Potency Evaluation: Consistent, Predictable Recovery of Hematopoietic Progenitor Cells (HPC) and High CD34+ Cell Viability in Stored Cord Blood Units (CBU) of the National Cord Blood Program (NCBP)‏ by Andromachi Scaradavou, Ludy Dobrila, M Susana Albano, Michal Tarnawski, Tracy Zhu, Chiseko Watanabe, Dan Zamfir, Rodica Ciubotariu, Dorothy Sung, and Pablo Rubinstein Blood Volume 128(22): December 2, 2016 ©2016 by American Society of Hematology

2 Andromachi Scaradavou et al. Blood 2016;128:2175
©2016 by American Society of Hematology

Download ppt "Cord Blood (CB) Stability and Potency Evaluation: Consistent, Predictable Recovery of Hematopoietic Progenitor Cells (HPC) and High CD34+ Cell Viability."

Similar presentations

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13):4793-4807 December 15, 2008 ©2008 by American Society of Hematology.

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience.

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience.
CD4 T cells: fates, functions, and faults by Jinfang Zhu, and William E. Paul Blood Volume 112(5):1557-1569 September 1, 2008 ©2008 by American Society.

CD4 T cells: fates, functions, and faults by Jinfang Zhu, and William E. Paul Blood Volume 112(5): September 1, 2008 ©2008 by American Society.
Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation.

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Formation of human hepatocytes by human hematopoietic stem cells in sheep by Graça Almeida-Porada, Christopher D. Porada, Jason Chamberlain, Ali Torabi,

Formation of human hepatocytes by human hematopoietic stem cells in sheep by Graça Almeida-Porada, Christopher D. Porada, Jason Chamberlain, Ali Torabi,
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
Do HSCs divide asymmetrically?

Do HSCs divide asymmetrically?
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
Neoplastic blood cells become pluripotent

Neoplastic blood cells become pluripotent
Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts by Boglarka Gyurkocza,

Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts by Boglarka Gyurkocza,
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima

by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima
TCR-MHC-peptide(s): in vivo veritas

TCR-MHC-peptide(s): in vivo veritas
Imatinib and ABCG2: who controls whom?

Imatinib and ABCG2: who controls whom?
Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening by Maria S. Albano, Patricia Taylor, Robert.

Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening by Maria S. Albano, Patricia Taylor, Robert.
Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura
Defects in DBA: more than meets the eye

Defects in DBA: more than meets the eye
by Muhammed A. Mir, Mrinal M. Patnaik, and Joerg Herrmann

by Muhammed A. Mir, Mrinal M. Patnaik, and Joerg Herrmann

Similar presentations

Ads by Google